Jackson Creek Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Jackson Creek Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,822	Closed	-$275K	–	313
2024 Q4	$275K	Sell	1,822 -12	-0.7%	-$1.87K	0.08%	284
2024 Q3	$285K	Buy	+1,834	New	+$274K	0.08%	270
2023 Q1	–	Sell	-2,531	Closed	-$396K	–	316
2022 Q4	$396K	Sell	2,531 -160	-6%	-$23K	0.18%	257
2022 Q3	$330K	Sell	2,691 -35	-1%	-$4.61K	0.15%	262
2022 Q2	$372K	Buy	+2,726	New	+$371K	0.15%	267
2021 Q2	–	Sell	-8,349	Closed	-$1.07M	–	316
2021 Q1	$1.07M	Buy	8,349 +103	+1%	+$12.7K	0.37%	134
2020 Q4	$983K	Sell	8,246 -1,419	-15%	-$173K	0.39%	118
2020 Q3	$1.11M	Buy	+9,665	New	+$1.14M	0.5%	20

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Jackson Creek Investment Advisors's DGX Position: Q1 2025 in Review

Jackson Creek Investment Advisors sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 1,822 shares — an estimated $275K sold.

Jackson Creek Investment Advisors first reported a position in DGX in Q3 2020 and held it in 8 quarters. The position peaked at $1.11M in Q3 2020. 967 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

Jackson Creek Investment Advisors reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
Jackson Creek Investment Advisors sold 1,822 Quest Diagnostics shares in Q1 2025, an estimated $275K.
Jackson Creek Investment Advisors first reported a position in Quest Diagnostics in Q3 2020 and held it in 8 quarters.
Jackson Creek Investment Advisors's Quest Diagnostics position peaked at $1.11M in Q3 2020.
967 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2025, filed 5 May 2025.